Trial Profile
Use of Ferumoxytol Enhanced Magnetic Resonance Angiography for Cardiovascular Assessment in Late-stage Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2019
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Renal failure
- Focus Diagnostic use
- 08 Feb 2019 Status changed from recruiting to completed.
- 21 Dec 2016 New trial record